Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients.

Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease.

Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure.

Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.

Congestive heart failure in coronary artery disease.

Pulmonary disease and congestive heart failure.

Congenital heart disease associated with hypertrophic cardiomyopathy.

Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy.

Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure.

Diagnosis and treatment of congestive heart failure secondary to dilated cardiomyopathy in a hedgehog.

Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.

Peritoneal Dialysis for Chronic Congestive Heart Failure.

Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases.

HLA in hypertrophic cardiomyopathy and rheumatic heart disease.

Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure.

Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy.

Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death.

Impaired forearm vasodilation to hyperosmolal stimuli in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy.

Incomplete Kawasaki disease: early findings consist of congestive heart failure due to valvular heart disease.

Genetics and genomics of dilated cardiomyopathy and systolic heart failure.

Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.

Molecular profiling of dilated cardiomyopathy that progresses to heart failure.

Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy.

Suggest Documents

Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease.

Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure.

Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.

Congestive heart failure in coronary artery disease.

Pulmonary disease and congestive heart failure.

Congenital heart disease associated with hypertrophic cardiomyopathy.

Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy.

Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure.

Diagnosis and treatment of congestive heart failure secondary to dilated cardiomyopathy in a hedgehog.

Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.

Peritoneal Dialysis for Chronic Congestive Heart Failure.

Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases.

HLA in hypertrophic cardiomyopathy and rheumatic heart disease.

Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure.

Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy.

Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death.

Impaired forearm vasodilation to hyperosmolal stimuli in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy.

Incomplete Kawasaki disease: early findings consist of congestive heart failure due to valvular heart disease.

Genetics and genomics of dilated cardiomyopathy and systolic heart failure.

Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.

Molecular profiling of dilated cardiomyopathy that progresses to heart failure.

Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy.

Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients.

Recommend Documents

Follow Us